Ordenar

Buscar

01/06/2026 One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain
Esteban-Fernández, A, Calvo-Bernal, B, López-Vilella, R, de Lara, G, Belarte-Tornero, LC, Barrantes-Castillo, M, Gómez-Otero, I, Nuñez-Villota, J, Robles-Gamboa, C, López-Aguilera, J, Torremocha-López, A, Melendo-Viu, M, Simón-Ramón, C, Fluvià-Burgués, P, Pastor-Pérez, FJ, Alonso-Salinas, G, García-Pinilla, JM, Pomares-Varó, A, Gayán-Ordás, J, González-Calle, D, Díez-Villanueva, P, Galván-Ruiz, M, Ortiz-Cortés, C, Caravaca-Pérez, P, Goena-Vives, C, Seller, J, Jiménez-Blanco, M, Codina, P, Vietiez, JM, Jordán-Martínez, L, López-Lluva, MT, Mena-Sebastià, E, Pájaro, P, Recio-Mayoral, A. One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain. ESC Heart Failure. 2026; 13(3)DOI:10.1093/eschf/xvag138. PMID:42128540. IF:3.700(Q1/3D).
01/06/2026 Clinicopathological correlates of FTLD-TDP type E: A deep phenotyping on an autopsy confirmed case
Aldecoa, I, Rubio-Guerra, S, García-Castro, J, Selma-González, J, Sala, I, Sánchez-Saudinós, B, Zhu, N, Barroeta, I, Rojas-Garcia, R, Turon-Sans, J, Carbayo, A, Camacho, V, Almenta, D, Pérez-Blanco, J, Bernal, S, González-Quereda, L, Caballero, G, Molina-Porcel, L, Dols-Icardo, O, Alcolea, D, Fortea, J, Lleó, A, Illán-Gala, I. Clinicopathological correlates of FTLD-TDP type E: A deep phenotyping on an autopsy confirmed case. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2026; 85(6)DOI:. PMID:. IF:3.000(Q2/4D).
01/06/2026 Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial
Flores-Umanzor, E, Cruz-González, I, Cepas-Guillén, P, Millán, X, Antúnez-Muiños, P, Asmarats, L, Laffond, A, Regueiro, A, López-Tejero, S, Li, CHP, Sanchis, L, Rodés-Cabau, J, Arzamendi, D, Freixa, X. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(6)DOI:10.1016/j.rec.2025.12.008. PMID:41412468. IF:4.900(Q1/2D).
01/06/2026 Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille, A, Morel, O, Alperi, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Muñoz-García, A, Nuche, J, Franzone, A, Urena, M, Asmarats, L, Regueiro, A, del Trigo, M, Auffret, V, del Val, D, Serra, V, Carmona, A, Avanzas, P, Fradejas-Sastre, V, Sanchez, I, Trichilo, M, Maneiro, N, Molaro, MI, Fischer, Q, Arzamendi, D, Flores-Umanzor, E, Oteo, JF, Nolf, M, Alfonso, F, Pockels, PD, Elkadiri, C, Cepas-Guillén, P, Avvedimento, M, Rodés-Cabau, J. Prognostic value of early haemodynamic valve deterioration after TAVI. EuroIntervention. 2026; 22(11)DOI:10.4244/EIJ-D-25-01370. PMID:42186872. IF:9.500(Q1/1D).
01/06/2026 The paradox of SMURF-less outcomes and its implication for diabetes
Cenko, E, Manfrini, O, Yoon, J, Bergami, M, Vasiljevic, Z, Mendieta, G, Zdravkovic, M, Vavlukis, M, Kedev, S, Milicic, D, Ottani, F, Badimon, L, Bugiardini, R. The paradox of SMURF-less outcomes and its implication for diabetes. European Heart Journal-Quality of Care and Clinical Outcomes. 2026; 12(4)DOI:10.1093/ehjqcco/qcag012. PMID:41606783. IF:4.600(Q1/2D).
01/06/2026 Parameter-efficient adaptation of foundational models for automated myocardial strain analysis
Bernardo, A, Mato, G, Calandrelli, M, Medus, J, Curiale, A. Parameter-efficient adaptation of foundational models for automated myocardial strain analysis. Biomedical Physics & Engineering Express. 2026; 12(3)DOI:10.1088/2057-1976/ae7c09. PMID:42276109. IF:(Q/D).